Business & Regulation

Without proper supply chain management, efforts to supply drugs to the developing world are wasted.

$100 million pledged to kick start investment in new research

Just how prevalent is pharmacogenomic information on European drug labels?

New technology interprets slang and banter to find out what people really think

Only you have the answer. Nominate now.

Is early and regular dialogue with regulatory agencies the key to success for smaller companies?

Could the Pfizer–Hospira deal be a stepping stone to a company split?

Research into rare diseases is on the rise, but are prices sustainable?

Research into rare diseases is on the rise, but are prices sustainable?

Can pharma get over its IP anxiety and embrace meaningful partnerships?